|
2025
|
Invention
|
High concentration bispecific antibody formulations.
Provided herein are stable aqueous pharmace... |
|
|
Invention
|
Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 a... |
|
|
Invention
|
Method of treating ulcerative colitis with an antibody to il-23.
A method of treating inflammato... |
|
|
Invention
|
Chromatography column qualification in manufacturing methods for producing anti-il12/23 antibody ... |
|
|
Invention
|
Radiolabeling of polypeptides.
Improved methods of radiolabeling antibodies using click chemistr... |
|
|
Invention
|
Materials and methods for designing, use and manufacture of improved biologic molecules. Material... |
|
|
Invention
|
Ovarian neoantigens and use thereof. Disclosed herein are methods and compositions for treating o... |
|
|
Invention
|
Use of amivantamab to treat head and neck cancer. The present invention relates to methods of tre... |
|
|
Invention
|
Il-23 specific antibodies for the treatment of systemic sclerosis.
A method of treating systemic... |
|
|
Invention
|
Patch assembly configured to facilitate needle insertion into a patient and delivery of medicamen... |
|
|
Invention
|
Use of amivantamab to treat colorectal cancer. The present invention relates to methods of treati... |
|
|
Invention
|
Injection aid, and method of making and using same. An injection aid can include a housing and an... |
|
2024
|
Invention
|
Combination therapies and patient stratification with bispecific ant-egfr/c-met antibodies.
The ... |
|
|
Invention
|
Site-specific conjugation of glycosylated monoclonal antibodies with transglutaminase.
Engineere... |
|
|
Invention
|
Enhancement of dna uptake into cell nucleus and methods of use. Disclosed are methods of increasi... |
|
|
Invention
|
Trispecific antibody targeting bcma, gprc5d and cd3 for the treatment of al amyloidosis. Embodime... |
|
|
Invention
|
Trispecific antibody targeting bcma, gprc5d and cd3 for the treatment of multiple myeloma. Embodi... |
|
|
Invention
|
Differentiation of human embryonic stem cells into single hormonal insulin positive cells.
The p... |
|
|
Invention
|
Enpp3 × cd3 bispecific antibodies and use thereof. The present disclosure provides ENPP3 binding ... |
|
|
Invention
|
Gprc5d antibodies with enhanced effector function and uses thereof.
Herein are antibodies or ant... |
|
|
Invention
|
Gprc5d antibodies with enhanced effector function and uses thereof. Herein are antibodies or anti... |
|
|
Invention
|
Cd33 antibodies, cd33/vδ2 multispecific antibodies and uses thereof. CD33 antibodies, and antigen... |
|
|
Invention
|
Compositions and methods to discover targeted oligonucleotide conjugates. A method of selecting a... |
|
|
Invention
|
Ai models, systems, and methods for predicting remanufacturing failures in car t drug products. S... |
|
|
Invention
|
Ai models, systems, and methods for manufacturing car t drug products with improved dose. Systems... |
|
|
Invention
|
Ai models, systems, and methods for manufacturing car t drug products with improved viability. Sy... |
|
|
Invention
|
Manufacturing systems, methods, and ai models for car t drug products with improved safety. Syste... |
|
|
Invention
|
Manufacturing systems, methods, and ai models for reducing out of specification (oos) car t drug ... |
|
|
Invention
|
Ai models, systems, and methods for reducing manufacturing failures in car t drug products. Syste... |
|
|
Invention
|
Ai models, systems, and methods for reducing growth terminations in car t cells. Systems and meth... |
|
|
Invention
|
Manufacturing systems, methods, and ai models for optimizing car t drug products. Embodiments her... |
|
|
Invention
|
Improved manufacturing of car t drug products based on car. Systems and methods are disclosed for... |
|
|
Invention
|
Methods for treatment of myeloproliferative neoplasms. Methods of inhibiting the growth or prolif... |
|
|
Invention
|
Antibodies specifically binding pd-1, tim-3 or pd-1 and tim-3 and their uses.
The present invent... |
|
|
Invention
|
Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or pharm... |
|
|
Invention
|
Methods in lentiviral manufacturing for production of car-t cell drug products.
The present appl... |
|
|
Invention
|
Enpp3 and cd3 binding agents and methods of use thereof.
The present disclosure provides ENPP3 b... |
|
|
Invention
|
Methods for treating multiple myeloma.
Embodiments of the present invention relate to methods of... |
|
|
Invention
|
Methods for treating multiple myeloma. The present disclosure is directed to treatment, for examp... |
|
|
Invention
|
Methods of treating non-small cell lung cancer. The present disclosure provides methods for treat... |
|
|
Invention
|
Methods for treatment of non-small cell lung cancer (nsclc). The present disclosure provides meth... |
|
2023
|
Invention
|
First line treatment in egfr exon 20 insertion-mutated advanced non-small cell lung cancer. The p... |
|
|
Invention
|
Methods for treating multiple myeloma. Embodiments of the present invention relate to methods of ... |
|
|
Invention
|
Syringe accessory |
|
|
Invention
|
Enhanced transfer of genetic instructions to effector immune cells.
A method for preparing an im... |
|
|
Invention
|
Shell for small vial to fit into injector or cap remover.
A shell that is configured to cover at... |
|
|
Invention
|
Methods and compositions comprising v beta 17 bispecific t cell engagers and bioengineered virus ... |
|
2022
|
Invention
|
Biosynthetic bioparatopic or bispecific binding molecules with enhanced effector functions.
Prov... |
|
|
Invention
|
Materials and methods of making or using il-23r binding proteins.
The present invention relates ... |
|
2019
|
G/S
|
Operating an online-marketplace featuring cell and gene therapy treatments and services; business... |
|
2016
|
G/S
|
Software as a service (SAAS) services, namely, hosting software for use by others for ordering, t... |
|
2008
|
G/S
|
Pharmaceutical and veterinary preparations, pharmaceutical preparations for the prevention and tr... |
|
2007
|
G/S
|
patient assistance program, namely, financial assistance for patients receiving pharmaceutical pr... |
|
2003
|
G/S
|
Pharmaceutical for the treatment of autoimmune diseases and autoimmune disorders. |
|
2002
|
G/S
|
pharmaceutical preparations for the treatment of autoimmune diseases and autoimmune disorders |
|
2001
|
G/S
|
Medical device used to infuse pharmaceuticals. |
|
|
G/S
|
Pharmaceutical for treatment of autoimmune diseases and disorders. |
|
1998
|
G/S
|
Pharmaceutical and medical preparations and substances; pharmaceutical compositions for the treat... |
|
|
G/S
|
Pharmaceutical compositions for treatment of autoimmune diseases and disorders. |
|
|
G/S
|
Pharmaceutical compositions for treatment of autoimmune diseases and disorders |
|
1996
|
G/S
|
Pharmaceutical preparations and products. |
|
1994
|
G/S
|
Pharmaceutical preparations for prevention and treatment of disease of the circulatory system. |
|
|
G/S
|
pharmaceutical preparations for the prevention and treatment of diseases of the circulatory system |
